Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Acasti Pharma (ACST) Q4 2023 Earnings
ACST
12
Feb
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.54
-0.39
-0.24
-0.09
Details
Expected EPS
N/A
Actual EPS
-0.21
Surprise EPS
-0.21
Surprise Percent
+∞%
Description
Acasti Pharma (ACST) has reported earnings of -0.21 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login